Sponsor or institution

Clinical trials and research at National Cancer Center, Japan

• 10Clinical trials
• 1New in 30 days
• 7Countries

Newest trials

All recruiting trials (10)

• Zolbetuximab added to FLOT and durvalumab before surgery for CLDN18.2-positive gastric/GEJ cancer

  This study tests whether adding zolbetuximab to FLOT chemotherapy plus durvalumab can improve tumor response before surgery in adults with CLDN18.2-positive gastric or GEJ cancer.

  Recruiting Phase 2 National Cancer Center, Japan · Saitama and 3 other locations · NCT07872722

• Perioperative HLX10 (serplulimab) with SOX chemotherapy for PD-L1 positive gastric/GEJ cancer

  This study tests whether adding HLX10 (serplulimab) to the SOX chemotherapy before and after surgery helps people with PD-L1 positive, locally advanced gastric or GEJ cancer compared to SOX alone.

  Recruiting at 5 sites Phase 2 National Cancer Center, Japan · Chiba, Chiba and 17 other locations · NCT07699939

• Enfortumab vedotin for advanced small bowel adenocarcinoma after platinum chemotherapy

  This trial tests whether enfortumab vedotin can shrink or control advanced small bowel adenocarcinoma in adults whose disease progressed on or who could not tolerate platinum-based chemotherapy.

  Recruiting at 3 sites Phase 2 National Cancer Center, Japan · Fukuoka and 2 other locations · NCT07347314

• Combination therapy of pembrolizumab and lenvatinib for unresectable cutaneous angiosarcoma

  This study is testing if a combination of two drugs, pembrolizumab and lenvatinib, can help people with a type of skin cancer called unresectable cutaneous angiosarcoma who haven't had success with other treatments.

  Recruiting at 6 sites Phase 2 National Cancer Center, Japan · Kashiwa and 5 other locations · NCT06673628

• Using binimetinib for patients with specific types of brain and pancreatic cancer

  This study is testing if a medication called binimetinib can help people with specific types of brain and pancreatic cancer feel better and improve their condition.

  Recruiting at 6 sites Phase 2 National Cancer Center, Japan · Kashiwa, Chiba and 5 other locations · NCT06159478

• Combination treatment for advanced or recurrent thymic carcinomas

  This study is testing a new combination of medicines to see if it can help people with advanced or recurrent thymic carcinomas feel better and manage their cancer more effectively.

  Recruiting Phase 2 National Cancer Center, Japan · Chūō, Tokyo · NCT05832827

• Assessing minimal residual disease in HER2-positive early breast cancer patients in Asia

  This study is trying to see if checking for tiny amounts of cancer DNA in the blood can help predict if HER2-positive early breast cancer patients in Asia are at risk of their cancer coming back after treatment.

  Recruiting National Cancer Center, Japan · Chuo-ku, Tokyo · NCT05433753

• Registry for patients with advanced rare cancers in Asia

  This study is collecting information from patients with advanced rare cancers in Asia to see how different treatments work and to find better, personalized options for their care.

  Recruiting at 16 sites National Cancer Center, Japan · Chuo-ku, Tokyo and 17 other locations · NCT05217407

• E7090 treatment for advanced solid tumors with FGFR gene changes (FORTUNE)

  This trial tests whether the drug E7090 can help people with advanced or recurrent solid tumors that have specific FGFR gene alterations.

  Recruiting at 7 sites Phase 2 National Cancer Center, Japan · Chuo-ku, Tokyo, Japan and 6 other locations · NCT04962867

• Evaluating the effects of prophylactic irradiation in esophageal cancer treatment

  This study tests if a new treatment combining chemotherapy and radiation can help people with esophageal cancer avoid the cancer coming back while keeping their esophagus and improving survival.

  Recruiting Phase 3 National Cancer Center, Japan · Tokyo · NCT04328948

Quick answers

How many clinical trials run by National Cancer Center, Japan are recruiting right now?

10, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in Japan (10 trials), South Korea (2 trials), Malaysia (1 trial), Philippines (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 7, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →